Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension.

[1]  M. Condorelli,et al.  Vagal Mediation of the Effects of Atrial Natriuretic Factor on Blood Pressure and Arterial Baroreflexes in the Rabbit , 1987, Circulation research.

[2]  M. Condorelli,et al.  Impaired responsiveness of the ventricular sensory receptor in hypertensive patients with left ventricular hypertrophy. , 1986, Circulation.

[3]  Andrew,et al.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[4]  N. Trippodo,et al.  Atrial Natriuretic Peptide Decreases Circulatory Capacitance in Areflexic Rats , 1986, Circulation research.

[5]  P. Erne,et al.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.

[6]  N. Trippodo,et al.  Hemodynamic effects of atrial natriuretic hormone. , 1986, Federation proceedings.

[7]  R. Rodeheffer,et al.  Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. , 1986, Journal of the American College of Cardiology.

[8]  M. Epstein,et al.  Increases in circulating atrial natriuretic factor during immersion-induced central hypervolaemia in normal humans. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  E. Bates,et al.  The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. , 1986, Circulation.

[10]  P. Weidmann,et al.  Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  J. Laragh,et al.  Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. , 1986, The American journal of physiology.

[12]  M. Cantin,et al.  Atrial Natriuretic Factor in Spontaneously Hypertensive Rats , 1986 .

[13]  J. Laragh,et al.  Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. , 1986, Hypertension.

[14]  D. Conklin,et al.  In vivo erythrocyte sodium concentration in human hypertension is reduced, not increased. , 1986, Journal of hypertension.

[15]  A. Shore,et al.  RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION , 1986, The Lancet.

[16]  S. Atlas.  Atrial natriuretic factor: a new hormone of cardiac origin. , 1986, Recent progress in hormone research.

[17]  J. Biollaz,et al.  Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers. , 1986, Journal of cardiovascular pharmacology.

[18]  J. Chimoskey,et al.  Atriopeptin II lowers cardiac output in conscious sheep. , 1985, The American journal of physiology.

[19]  K. Kangawa,et al.  The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats. , 1985, Circulation research.

[20]  A. Richards,et al.  Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.

[21]  A. Simon,et al.  Blood pressure in the 'low-pressure system' and cardiac performance in essential hypertension. , 1985, Journal of hypertension.

[22]  I. Tikkanen,et al.  PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[23]  M. Currie,et al.  Inhibition of Aldosterone Biosynthesis by Atriopeptins in Rat Adrenal Cells , 1985, Circulation research.

[24]  C. Saper,et al.  Atriopeptins as cardiac hormones. , 1985, Hypertension.

[25]  J. Laragh,et al.  Effect of Atrial Natriuretic Factor on Blood Pressure, Renin, and Aldosterone in Goldblatt Hypertension , 1985, Hypertension.

[26]  M. Currie,et al.  Atriopeptins: renal-specific vasodilators in conscious dogs. , 1985, The American journal of physiology.

[27]  M. Cantin,et al.  The heart and the atrial natriuretic factor. , 1985, Endocrine reviews.

[28]  J. Laragh,et al.  Atrial natriuretic factor: structure and functional properties. , 1985, Kidney international.

[29]  J. Smits,et al.  Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. , 1985, Circulation research.

[30]  A. Loewy,et al.  Comparative Vascular Pharmacology of the Atriopeptins , 1985, Circulation research.

[31]  K. Kangawa,et al.  Hemodynamic effects of α-human atrial natriuretic polypeptide (α-HANP) in rats , 1985 .

[32]  M. Webster,et al.  RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[33]  J. Laragh,et al.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. , 1984, The American journal of medicine.

[34]  T. Goodfriend,et al.  Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. , 1984, Life sciences.

[35]  U. Ackermann,et al.  Cardiovascular effects of atrial extracts in anesthetized rats. , 1984, Canadian journal of physiology and pharmacology.

[36]  R. Nutt,et al.  Vasodilator profile of synthetic atrial natriuretic factor. , 1984, European journal of pharmacology.

[37]  J. Rapp,et al.  Inhibition of aldosterone production by an atrial extract. , 1984, Science.

[38]  M. Currie,et al.  An atrial peptide is a potent renal vasodilator substance. , 1984, Circulation research.

[39]  J. Laragh,et al.  Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. , 1984, Hypertension.

[40]  M. Currie,et al.  Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. , 1983, Science.

[41]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[42]  T. Waterston.  Fluids for diarrhoea in young children. , 1977, Lancet.

[43]  J. Clements,et al.  Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. , 1974, The Journal of clinical endocrinology and metabolism.

[44]  D. Goldstein,et al.  Early detection of implantation using a radioimmunoassay specific for human chorionic gonadotropin. , 1973, The Journal of clinical endocrinology and metabolism.

[45]  J. Ménard,et al.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. , 1972, Endocrinology.

[46]  A. Anton,et al.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. , 1962, The Journal of pharmacology and experimental therapeutics.

[47]  A. C. Burton,et al.  RECOMMENDATIONS for human blood pressure determinations by sphygmomanometers. , 1967, Journal of the American Medical Association.

[48]  L. Fatti.  Perspex specimen-boxes. , 1947, Lancet.